Effects of beraprost sodium on improvement of insulin resistance in patients with type 2 diabetes and peripheral arterial disease
Not Applicable
- Conditions
- Patients with type 2 diabetes and peripheral arterial disease
- Registration Number
- JPRN-UMIN000003089
- Lead Sponsor
- Graduate School of Medicine, University of Tokyo Department of Metabolic Diseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
- Patients with bleeding tendancy - Patients with severe renal dysfunction - Patients with liver dysfunction - Patients with a past hystory of drug hypersensitivity - Pregnant women or women with breast-feeding - Patients who took prostaglandin derivatives within 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glucose infusion rate on euglycemic hyperinsulinemic clamp (0, 12 weeks)
- Secondary Outcome Measures
Name Time Method